Institute of BioMedical Research Corp. (MRES)
0.0030
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Institute of BioMedical Research Shareholders Equity (Quarterly) : -0.5829M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5829M |
| March 31, 2026 | -0.5784M |
| December 31, 2025 | 0.2639M |
| September 30, 2025 | 0.3644M |
| June 30, 2025 | 0.4891M |
| March 31, 2025 | 0.5839M |
| December 31, 2024 | 1.209M |
| September 30, 2024 | 0.2564M |
| June 30, 2024 | 1.152M |
| March 31, 2024 | 1.484M |
| December 31, 2023 | -0.0827M |
| September 30, 2023 | -0.4465M |
| June 30, 2023 | -0.2954M |
| March 31, 2023 | -0.1212M |
| December 31, 2022 | -0.3083M |
| September 30, 2022 | -0.0879M |
| June 30, 2022 | -0.4887M |
| March 31, 2022 | -0.6374M |
| December 31, 2021 | -0.591M |
| September 30, 2021 | -0.5439M |
| June 30, 2021 | -0.4821M |
| March 31, 2021 | -0.4704M |
| December 31, 2020 | -0.4589M |
| September 30, 2020 | -0.4477M |
| June 30, 2020 | -0.4368M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4261M |
| December 31, 2019 | -0.4157M |
| September 30, 2019 | -0.4056M |
| June 30, 2019 | -0.3957M |
| March 31, 2019 | -0.3861M |
| December 31, 2018 | -0.3771M |
| September 30, 2018 | -0.3679M |
| June 30, 2018 | -0.359M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 2.343M |
| March 31, 2015 | 1.103M |
| December 31, 2014 | 1.443M |
| September 30, 2014 | 1.277M |
| June 30, 2014 | 0.5538M |
| March 31, 2014 | 1.030M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Cavitation Technologies, Inc. | -0.467M |
| Clene, Inc. | -24.78M |
| Bon Natural Life Ltd. | -- |
| Biohaven Ltd. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0466M |
| Total Liabilities (Quarterly) | 0.6415M |
| Current Ratio | 0.0348 |